CRP testing can be used for additional risk stratification in individuals already identified with one abnormal system (e.g., isolated hypertension or low HDL-C) to identify those with cumulative, multisystem dysregulation who are at the highest risk. The gene discussed is CRP; the disease is Hypertension.